Finland is one of the world's hotspots for health R&D, consistently ranked among the world's leading countries in healthcare, education, innovation, digitalization and good governance.
As one of the first countries to compile social and welfare data in digital registries, and with a 100% population penetration in electronic health records, Finland's digital health data is globally unique when it comes to their scope and depth.
Due to the well-curated health and social services data resources, Finland is in the fore front of data-driven precision medicine, making Finland a trusted location for pharmaceutical research and development operations.
In addition to unique health data repositories, several other factors make Finland an attractive location for developing innovations in the field of data-driven solutions: broad-based skills of highly educated people; people's trust in public authorities; a tradition of public–private partnership as well as forward-looking, innovation friendly legislation.
But how does access to accurate and comprehensive health data benefit companies and for example their R&D operations in action? Listen our latest podcast episode to learn more – joining us in the conversation are Johanna Mäkelä from FINBB, and Jussi Leinonen from Bayer.